Papers
A range of topical papers
Clinical Trial Management Value Added Trials
The interest in the use of adaptive clinical trials is definitely rising – but why? Tom Parke of Tessella considers the expectations for these methods, and what they can offer.
The Value Proposition
Tom Parke at Tessella demonstrates the benefits that adaptive clinical trials can provide, and argues that although they may require greater initial effort, the end result is a more efficient development programme. Pharmaceutical and biotech companies are increasingly interested in the use of ‘adaptive’ clinical trials to improve the process of drug development. By an ‘adaptive trial’, we mean a trial that is designed from the outset to review key response data as we collect it, and carry out certain pre-specified adaptations in the light of what we learn.
Whitepaper: Coherent IT Strategy for Fast-Moving R&D
What is your company’s IT Strategy for R&D and how effectively is that strategy helping drive your company’s success? There are nearly as many answers to those questions as there are companies in the biopharmaceutical industry.